Nancy M Allen LaPointe

Summary

Affiliation: Duke University Medical Center
Country: USA

Publications

  1. ncbi request reprint Outpatient use of anticoagulants, rate-controlling drugs, and antiarrhythmic drugs for atrial fibrillation
    Nancy M Allen LaPointe
    Duke Clinical Research Institute, Duke University Medical Center, Durham, NC 27715, USA
    Am Heart J 154:893-8. 2007
  2. ncbi request reprint Patient-reported frequency of taking aspirin in a population with coronary artery disease
    Nancy M Allen LaPointe
    Duke CERTs Centers for Education and Research on Therapeutics at the Duke Clinical Research Institute, Durham, North Carolina 27715, USA
    Am J Cardiol 89:1042-6. 2002
  3. doi request reprint Rhythm versus rate control in the contemporary management of atrial fibrillation in-hospital
    Nancy M Allen LaPointe
    Duke Clinical Research Institute, Duke University Medical Center, Durham, North Carolina, USA
    Am J Cardiol 101:1134-41. 2008
  4. doi request reprint Association between mortality and persistent use of beta blockers and angiotensin-converting enzyme inhibitors in patients with left ventricular systolic dysfunction and coronary artery disease
    Nancy M Allen LaPointe
    Duke Clinical Research Institute, Duke University Medical Center, Durham, North Carolina, USA
    Am J Cardiol 103:1518-24. 2009
  5. doi request reprint Use of beta-blockers in patients with an implantable cardioverter defibrillator
    Nancy M Allen LaPointe
    School of Medicine, Duke University, Duke Clinical Research Institute, Durham, NC 27705, USA
    Ann Pharmacother 43:1189-96. 2009
  6. pmc Relation of patient age and mortality to reported contraindications to early beta-blocker use for non-ST-elevation acute coronary syndrome
    Nancy M Allen LaPointe
    Duke Clinical Research Institute, Durham, North Carolina, USA
    Am J Cardiol 104:1324-9. 2009
  7. doi request reprint In-hospital management of patients with atrial flutter
    Nancy M Allen LaPointe
    Duke Clinical Research Institute, Duke University Medical Center, Durham, NC, USA
    Am Heart J 159:370-6. 2010
  8. ncbi request reprint Changes in beliefs about medications during long-term care for ischemic heart disease
    Nancy M Allen LaPointe
    Division of Clinical Pharmacology and Duke Clinical Research Institute, Duke University Medical Center, Durham NC, USA
    Am Heart J 159:561-9. 2010
  9. doi request reprint Extent of and reasons for nonuse of implantable cardioverter defibrillator devices in clinical practice among eligible patients with left ventricular systolic dysfunction
    Nancy M Allen LaPointe
    Duke University Medical Center, Duke Clinical Research Institute, Durham, NC 27705, USA
    Circ Cardiovasc Qual Outcomes 4:146-51. 2011
  10. doi request reprint Association between patient beliefs and medication adherence following hospitalization for acute coronary syndrome
    Nancy M Allen LaPointe
    Division of Clinical Pharmacology, Duke Clinical Research Institute, Duke University Medical Center, Durham, NC, USA
    Am Heart J 161:855-63. 2011

Detail Information

Publications26

  1. ncbi request reprint Outpatient use of anticoagulants, rate-controlling drugs, and antiarrhythmic drugs for atrial fibrillation
    Nancy M Allen LaPointe
    Duke Clinical Research Institute, Duke University Medical Center, Durham, NC 27715, USA
    Am Heart J 154:893-8. 2007
    ..We explored the use of anticoagulants, rate-controlling drugs, and antiarrhythmic drugs in patients with AF during the 4 years surrounding publication of these guidelines...
  2. ncbi request reprint Patient-reported frequency of taking aspirin in a population with coronary artery disease
    Nancy M Allen LaPointe
    Duke CERTs Centers for Education and Research on Therapeutics at the Duke Clinical Research Institute, Durham, North Carolina 27715, USA
    Am J Cardiol 89:1042-6. 2002
    ..Although the rate of aspirin use in this population was higher than previously reported, an estimated 6% of eligible patients were not receiving antiplatelet therapy...
  3. doi request reprint Rhythm versus rate control in the contemporary management of atrial fibrillation in-hospital
    Nancy M Allen LaPointe
    Duke Clinical Research Institute, Duke University Medical Center, Durham, North Carolina, USA
    Am J Cardiol 101:1134-41. 2008
    ..Some observations, such as greater use of the rate-control strategy with increasing age, were consistent with recommendations, but others, such as lower use of warfarin in the rate-control group, were not...
  4. doi request reprint Association between mortality and persistent use of beta blockers and angiotensin-converting enzyme inhibitors in patients with left ventricular systolic dysfunction and coronary artery disease
    Nancy M Allen LaPointe
    Duke Clinical Research Institute, Duke University Medical Center, Durham, North Carolina, USA
    Am J Cardiol 103:1518-24. 2009
    ..We were unable to demonstrate a statistically significant association between persistent ACEI/ARB use and survival...
  5. doi request reprint Use of beta-blockers in patients with an implantable cardioverter defibrillator
    Nancy M Allen LaPointe
    School of Medicine, Duke University, Duke Clinical Research Institute, Durham, NC 27705, USA
    Ann Pharmacother 43:1189-96. 2009
    ..beta-Blockers are also indicated in most patients who have an indication for an ICD; however, their use in this population is not well described. Some clinicians may be unaware of the recommendation for beta-blockers in this population...
  6. pmc Relation of patient age and mortality to reported contraindications to early beta-blocker use for non-ST-elevation acute coronary syndrome
    Nancy M Allen LaPointe
    Duke Clinical Research Institute, Durham, North Carolina, USA
    Am J Cardiol 104:1324-9. 2009
    ..In conclusion, the results did not indicate any disparity in reporting the contraindications according to patient age...
  7. doi request reprint In-hospital management of patients with atrial flutter
    Nancy M Allen LaPointe
    Duke Clinical Research Institute, Duke University Medical Center, Durham, NC, USA
    Am Heart J 159:370-6. 2010
    ..Little is known about the use of drugs or procedures for management of atrial flutter (AFl) in routine clinical practice. We describe the extent of use of conversion therapies during AFl hospitalizations...
  8. ncbi request reprint Changes in beliefs about medications during long-term care for ischemic heart disease
    Nancy M Allen LaPointe
    Division of Clinical Pharmacology and Duke Clinical Research Institute, Duke University Medical Center, Durham NC, USA
    Am Heart J 159:561-9. 2010
    ..Changes in these beliefs during long-term care have not previously been studied and were evaluated for purposes of this analysis...
  9. doi request reprint Extent of and reasons for nonuse of implantable cardioverter defibrillator devices in clinical practice among eligible patients with left ventricular systolic dysfunction
    Nancy M Allen LaPointe
    Duke University Medical Center, Duke Clinical Research Institute, Durham, NC 27705, USA
    Circ Cardiovasc Qual Outcomes 4:146-51. 2011
    ..The extent and documented reasons for nonuse of ICDs among patients with left ventricular systolic dysfunction are unknown...
  10. doi request reprint Association between patient beliefs and medication adherence following hospitalization for acute coronary syndrome
    Nancy M Allen LaPointe
    Division of Clinical Pharmacology, Duke Clinical Research Institute, Duke University Medical Center, Durham, NC, USA
    Am Heart J 161:855-63. 2011
    ....
  11. ncbi request reprint Enoxaparin dosing and associated risk of in-hospital bleeding and death in patients with non ST-segment elevation acute coronary syndromes
    Nancy M Allen LaPointe
    Duke Clinical Research Institute, Duke University Medical Center, Durham, NC 27705, USA
    Arch Intern Med 167:1539-44. 2007
    ..The extent to which bleeding risk is attributable to excess dosing of enoxaparin is unclear...
  12. pmc Patient receipt and understanding of written information provided with isotretinoin and estrogen prescriptions
    Nancy M Allen LaPointe
    Duke Center for Education and Research on Therapeutics, Duke Clinical Research Institute, Durham, NC 27715, USA
    J Gen Intern Med 22:98-101. 2007
    ..Medication guides (MG) and mandatory patient package inserts (MPPI) are required with some prescription medications...
  13. ncbi request reprint Multifaceted intervention to promote beta-blocker use in heart failure
    Nancy M Allen LaPointe
    Center for Education and Research on Therapeutics, Duke Clinical Research Institute, Durham, NC 27715, USA
    Am Heart J 151:992-8. 2006
    ..Despite a survival benefit and guideline recommendation for beta-blockers in left ventricular systolic dysfunction, beta-blockers are underused in clinical practice...
  14. ncbi request reprint Practitioner acceptance of the dofetilide risk-management program
    Nancy M Allen LaPointe
    Duke Center for Education and Research on Therapeutics, Duke Clinical Research Institute, Durham, North Carolina 27715, USA
    Pharmacotherapy 22:1041-6. 2002
    ..To assess the opinions and knowledge retention of practitioners after participation in the dofetilide risk-management program...
  15. ncbi request reprint Knowledge deficits related to the QT interval could affect patient safety
    Nancy M Allen LaPointe
    Duke CERTs Centers for Education and Research on Therapeutics at the Duke Clinical Research Institute, Duke University Medical Center, Durham, NC 27715, USA
    Ann Noninvasive Electrocardiol 8:157-60. 2003
    ..S. Food and Drug Administration. This led us to assess the health care practitioners' knowledge of the QT interval and medications that may prolong it...
  16. ncbi request reprint New antiarrhythmic agents for atrial fibrillation and atrial flutter: United States drug market response as an indicator of acceptance
    Nancy M Allen LaPointe
    Duke Center for Education and Research on Therapeutics, Duke Clinical Research Institute, P O Box 17969, Durham, NC 27715, USA
    Pharmacotherapy 23:1316-21. 2003
    ....
  17. ncbi request reprint Evaluation of the dofetilide risk-management program
    Nancy M Allen LaPointe
    Duke Center for Education and Research on Therapeutics and the Division of Cardiology, Duke Clinical Research Institute, Durham, NC 27715, USA
    Am Heart J 146:894-901. 2003
    ..We investigated whether this program improved adherence to dosing and monitoring recommendations for dofetilide as compared with sotalol...
  18. ncbi request reprint Frequency of high-risk use of QT-prolonging medications
    Nancy M Allen LaPointe
    Duke Center for Education and Research on Therapeutics, Duke Clinical Research Institute, Duke University Medical Center, Durham, NC 27715, USA
    Pharmacoepidemiol Drug Saf 15:361-8. 2006
    ..Concurrent use of more than one QT-prolonging drug or a QT-prolonging drug with a drug that alters its pharmacokinetic profile is an important risk factor for adverse outcomes...
  19. doi request reprint Unfractionated heparin dosing and risk of major bleeding in non-ST-segment elevation acute coronary syndromes
    Chiara Melloni
    Division of Cardiology and Duke Clinical Research Institute, Duke University Medical Center, Durham, NC 27705, USA
    Am Heart J 156:209-15. 2008
    ..Unfractionated heparin (UFH) is a mainstay of treatment for patients with non-ST-segment elevation acute coronary syndromes (NSTE ACS), but the practice of weight-adjusted bolus and infusion dosing has not been carefully evaluated...
  20. doi request reprint Educational videos to reduce racial disparities in ICD therapy via innovative designs (VIVID): a randomized clinical trial
    Kevin L Thomas
    Duke Clinical Research Institute, Durham, NC 27710, USA
    Am Heart J 166:157-63. 2013
    ..We conducted a pilot study to assess the feasibility of testing this hypothesis in a randomized trial...
  21. ncbi request reprint Prescription of QT-prolonging drugs in a cohort of about 5 million outpatients
    Lesley H Curtis
    Center for Clinical and Genetic Economics, Duke University Medical Center, Durham, North Carolina 27510, USA
    Am J Med 114:135-41. 2003
    ..Large pharmaceutical claims databases are useful for detecting potentially harmful prescribing behaviors, but better clinical evidence on medication safety is needed before such a system can be implemented fully...
  22. pmc A survey of health care practitioners' knowledge of the QT interval
    Sana M Al-Khatib
    Duke Center for Education and Research on Therapeutics, Duke Clinical Research Institute, Durham, NC 27715, USA
    J Gen Intern Med 20:392-6. 2005
    ..To assess health care practitioners' ability to correctly measure the QT interval, and to identify factors and medications that may increase the risk of QT-interval prolongation and torsades de pointes...
  23. ncbi request reprint Economic effects of beta-blocker therapy in patients with heart failure
    Patricia A Cowper
    Outcomes Research and Assessment Group, Durham, North Carolina 27715, USA
    Am J Med 116:104-11. 2004
    ..We assessed the economic effects of beta-blocker therapy from various perspectives: societal, Medicare, hospital, physician, and patient...
  24. ncbi request reprint Patient-focused intervention to improve long-term adherence to evidence-based medications: a randomized trial
    Sara Bristol Calvert
    Duke Clinical Research Institute, Duke University Medical Center, Durham, NC, USA
    Am Heart J 163:657-65.e1. 2012
    ..Nonadherence to cardiovascular medications is a significant public health problem. This randomized study evaluated the effect on medication adherence of linking hospital and community pharmacists...
  25. pmc Adherence to guideline recommendations for antiarrhythmic drugs in atrial fibrillation
    Nancy M Allen LaPointe
    Duke Clinical Research Institute, Durham, NC Electronic address
    Am Heart J 166:871-8. 2013
    ..It is unknown to what extent these recommendations are being implemented in clinical practice...
  26. ncbi request reprint Excess dosing of antiplatelet and antithrombin agents in the treatment of non-ST-segment elevation acute coronary syndromes
    Karen P Alexander
    Duke University Medical Center, Duke Clinical Research Institute, Durham, NC 27715, USA
    JAMA 294:3108-16. 2005
    ..Effective medical care assumes delivery of evidence-based medicines to appropriate patients with doses comparable to those studied...